The phase III corona vaccine trial started last week. COVID-19 affects every country in the world and without a vaccine, the WHO estimates that almost 80% of the world will be infected at some point.
The Ndlovu Research Unit is the only research unit in Limpopo participating in the Covid-19 vaccine trial. In preparation for this, the facilities have been remodeled to meet the highest standards. New staff quarters were also built to accommodate the research team and families nearby.
We are pleased that the Ndlovu Research Center is one of the research centers participating in this study in the fight against such a tough pandemic that has affected the whole world.
